Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Paradiso

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Hereditary Cancer in Clinical Practice|October 28, 2021
Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini reviewA Daniele, R Divella, B Pilato, et al.
Journal of Personalized Medicine|April 3, 2021
Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin's Lymphoma SurvivorsA Daniele, A Guarini, S De Summa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2018
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot studyC K Y Ng, G G Di Costanzo, N Tosti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Hereditary Cancer in Clinical Practice|October 28, 2021
Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini reviewA Daniele, R Divella, B Pilato, et al.
Journal of Personalized Medicine|April 3, 2021
Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin's Lymphoma SurvivorsA Daniele, A Guarini, S De Summa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2018
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot studyC K Y Ng, G G Di Costanzo, N Tosti, et al.
Pageof 2